Eli Lilly Posts Earnings Beat. The Stock Is Rising.

[ad_1]

Excitement over the sales potential of Lilly’s new obesity medicine has sent shares soaring this year.

[ad_2]

Source link


Comments

Leave a Reply

Your email address will not be published. Required fields are marked *